ASSESSMENT OF ANTIMICROBIAL EFFICACY OF KOHL/KAJAL PREPARED BY DIFFERENT INDIAN METHODS AGAINST SELECTED MICROBIAL STRAINS

Objective: To prepare and evaluate different types of Kajal formulations and evaluation of its antimicrobial activity along with preliminary verification of the content responsible for the said effect. Methods: We have prepared kajal formulations by use of different metal plates, marble tile, ghee and Aloe vera mucilage and tried to verify the antimicrobial effect attributed to the formulation by these substances. Results: Carbon soot obtained from the use of copper plate showed more antimicrobial potential against Staphylococcus aureus, Pseudomonas aeruginosa and E. coli, with zones of inhibition 18±0.235 mm, 17±0.124 mm and 19±0.528 mm respectively. Also this formulation at different concentrations when compared with Ciprofloxacin exhibited promising results. Moreover, this formulation when used with Ciprofloxacin at a concentration of (50:50) revealed a synergistic effect against the clinically resistant strains of P. aeruginosa, with zone of inhibition 22±0.578 mm and 20±0.987 mm at a concentration of 10 and 5 µg ml-1 respectively, whereas, Ciprofloxacin exhibited zone of inhibition of 26±0.457 mm and 24±0.751 mm at the similar concentrations. To assess the effectiveness of Aloe vera we used marbles tiles for collection of carbon soot. The zones of inhibition observed for Kohl formulations prepared by using carbon soot collected from marble tiles impregnated with Aloe vera mucilage exhibited less antimicrobial activity than that of copper soot against the selected microbial strains. Conclusion: All the prepared kajal formulations exhibited antimicrobial activity. Aloe vera and copper soot is responsible for significant antimicrobial activity and when combined with Ciprofloxacin it showed synergistic activity against the clinically resistant strains of P. aeruginosa

Utjecaj sadržaja lijeka i veličine aglomerata na tabletiranje i oslobađanje bromheksin hidroklorida iz aglomerata s talkom pripremljenih kristalokoaglomeracijom

The objective of the investigation was to study the effect of bromhexine hydrochloride (BXH) content and agglomerate size on mechanical, compressional and drug release properties of agglomerates prepared by crystallo-co-agglomeration (CCA). Studies on optimized batches of agglomerates (BXT1 and BXT2) prepared by CCA have showed adequate sphericity and strength required for efficient tabletting. Trend of strength reduction with a decrease in the size of agglomerates was noted for both batches, irrespective of drug loading. However, an increase in mean yield pressure (14.189 to 19.481) with an increase in size was observed for BXT2 having BXH-talc (1:15.7). Surprisingly, improvement in tensile strength was demonstrated by compacts prepared from BXT2, due to high BXH load, whereas BXT1, having a low amount of BXH (BXH-talc, 1:24), showed low tensile strength. Consequently, increased tensile strength was reflected in extended drug release from BXT2 compacts (Higuchi model, R2 = 0.9506 to 0.9981). Thus, it can be concluded that interparticulate bridges formed by BXH and agglomerate size affect their mechanical, compressional and drug release properties.Cilj rada bio je praćenje utjecaja sadržaja bromheksidin hidroklorida (BXH) i veličine aglomerata na mehanička svojstva, kompresivnost i oslobađanje ljekovite tvari iz aglomerata pripravljenih kristalokoaglomeracijom (CCA). Optimizirani pripravci aglomerata (BXT1 i BXT2) pripravljeni CCA metodom pokazuju adekvatnu sferičnost i čvrstoću potrebnu za učinkovito tabletiranje. U oba pripravka se smanjenjem veličine aglomerata smanjivala i čvrstoća, neovisno o količini ljekovite tvari. Međutim, povećanje prosječnog tlaka s povećanjem veličine čestica primijećeno je u pripravku BXT2 s omjerom BXH-talk 1:15,7. Iznenađuje da su kompakti pripravljeni iz BXT2, s visokim sadržajem BXH, imali veću vlačnu čvrstoću, dok su BXT1 s niskim sadržajem BXH (BXH-talk, 1:24) imali manju čvrstoću. Veća vlačna čvrstoća imala je za posljedicu produljeno oslobađanje ljekovite tvari iz BXT2 (Higuchijev model, R2 = 0,9506 do 0,9981). Može se zaključiti da mostovi među česticama BXH i veličina aglomerata utječu na njihova mehanička i kompresivna svojstva te na oslobađanje ljekovite tvari

Influence of esomeprazole on the pharmacodynamic activity of thiazolidinediones (pioglitazone and rosiglitazone) in animal models

Drug-drug interaction studies are essential building blocks in drug development. Thiazolidinediones (TZDs: pioglitazone, and rosiglitazone) are peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists, which have been widely used in the treatment of type 2 diabetes as insulin sensitizers. Esomeprazole, the (S) -isomer of omeprazole, is the first proton pump inhibitor (PPI) developed as a single isomer for the treatment of acid-peptic disease by specific inhibition of H+K+- ATPase in gastric parietal cells. The role of esomeprazole on the pharmacodynamic activity of TZDs is not currently known; however, there is the possibility of drug interaction (DI) leading to decreased activity of TZDs. The study was planned to investigate the safety and effectiveness of TZDs therapy in the presence of esomeprazole in animal models

Influence of esomeprazole on the pharmacodynamic activity of thiazolidinediones (pioglitazone and rosiglitazone) in animal Models

Drug-drug interaction studies are essential building blocks in drug development. Thiazolidinediones (TZDs: pioglitazone, and rosiglitazone) are peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists, which have been widely used in the treatment of type 2 diabetes as insulin sensitizers. Esomeprazole, the (S) -isomer of omeprazole, is the first proton pump inhibitor (PPI) developed as a single isomer for the treatment of acid-peptic disease by specific inhibition of H+K+- ATPase in gastric parietal cells. The role of esomeprazole on the pharmacodynamic activity of TZDs is not currently known; however, there is the possibility of drug interaction (DI) leading to decreased activity of TZDs. The study was planned to investigate the safety and effectiveness of TZDs therapy in the presence of esomeprazole in animal models

Extrusion-Spheronization of Talc using Microcrystalline Cellulose as a Pellet Aid: Part I

NoThe aims of the present work were to pelletize talc by extrusion-spheronization technique using microcrystalline cellulose (MCC) as a pelletization aid and to study its performance as a neutral substrate for coating. A 32 factorial design was used to study the effect of independent variables (X1, amount of talc, and X2, MCC) on pellet properties